A randomised, controlled, assessor-blind, clinical trial to compare Hedrin® 4% dimeticone lotion with Hedrin® 4% lotion Dev 42 in the treatment of head lice

Thornton & Ross Ltd (UK)0 sites72 target enrollmentMarch 19, 2009

Overview

Registry

who.int

Start Date

March 19, 2009

End Date

May 31, 2008

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Thornton & Ross Ltd (UK)

•1\. Both males and females, aged 4 years and over with no upper age limit
•2\. Participants who upon examination, are confirmed to have live head lice
•3\. Participants who give written informed consent, or if the participant is under 16 years of age whose parent/guardian gives written informed consent to participate in the study
•4\. Participants who will be available for follow\-up visits by study team members over the 14 days following first treatment

•1\. Participants with a known sensitivity to any of the ingredients in Hedrin® 4% lotion or Hedrin® 4% lotion Dev 42
•2\. Participants with a secondary bacterial infection of the scalp (e.g. impetigo) or who have an active long\-term scalp condition (e.g. psoriasis of the scalp)
•3\. Participants who have been treated with other head lice products within the previous two weeks
•4\. Participants who have bleached hair, or hair that has been permanently waved within the previous four weeks
•5\. Participants who have been treated with the antibiotics co\-trimoxazole or trimethoprim within the previous four weeks, or who are currently taking such a course
•6\. Pregnant or nursing mothers
•7\. Participants who have participated in another clinical study within 1 month before entry to this study
•8\. Participants who have already participated in this clinical study